Jackson, W C <br/><br/>
A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy.  [electronic resource] 

 -  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology  12 2019 
 - 101-107 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0887 
<br/><br/><label>Standard No.: </label>10.1016/j.radonc.2019.07.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Carcinoma, Hepatocellular--radiotherapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Liver Neoplasms--radiotherapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Radiation Injuries--prevention & control<br/>Radiosurgery--adverse effects<br/>Radiotherapy Dosage<br/>Treatment Outcome